The Glioma International Case-Control Study: A Report From the Genetic Epidemiology of Glioma International Consortium.

Decades of research have established only a few etiological factors for glioma, which is a rare and highly fatal brain cancer. Common methodological challenges among glioma studies include small sample sizes, heterogeneity of tumor subtypes, and retrospective exposure assessment. Here, we briefly describe the Glioma International Case-Control (GICC) Study (recruitment, 2010-2013), a study being conducted by the Genetic Epidemiology of Glioma International Consortium that integrates data from multiple data collection sites, uses a common protocol and questionnaire, and includes biospecimen collection. To our knowledge, the GICC Study is the largest glioma study to date that includes collection of blood samples, which will allow for genetic analysis and interrogation of gene-environment interactions.

[1]  L. Morgan,et al.  The epidemiology of glioma in adults: a "state of the science" review. , 2015, Neuro-oncology.

[2]  R. Gibbs,et al.  Targeted Sequencing in Chromosome 17q Linkage Region Identifies Familial Glioma Candidates in the Gliogene Consortium , 2015, Scientific Reports.

[3]  Jill S Barnholtz-Sloan,et al.  Epidemiology of gliomas. , 2015, Cancer treatment and research.

[4]  R. Gibbs,et al.  Germline mutations in shelterin complex genes are associated with familial glioma. , 2015, Journal of the National Cancer Institute.

[5]  J. Barnholtz-Sloan,et al.  The epidemiology of glioma in adults: a "state of the science" review. , 2014, Neuro-oncology.

[6]  J. Barnholtz-Sloan,et al.  CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. , 2012, Neuro-oncology.

[7]  Hendrik Koffijberg,et al.  Individual Participant Data Meta-Analysis for a Binary Outcome: One-Stage or Two-Stage? , 2013, PloS one.

[8]  C. Mathers,et al.  GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer , 2013 .

[9]  Melissa Bondy,et al.  Genome-wide association study of glioma and meta-analysis , 2012, Human Genetics.

[10]  T. Pietsch,et al.  Concordance between local, institutional, and central pathology review in glioblastoma: implications for research and practice: a pilot study. , 2012, Neurology India.

[11]  Min Zhang,et al.  Population versus hospital controls for case-control studies on cancers in Chinese hospitals , 2011, BMC medical research methodology.

[12]  Ying Mao,et al.  Association of sequence variants on chromosomes 20, 11, and 5 (20q13.33, 11q23.3, and 5p15.33) with glioma susceptibility in a Chinese population. , 2011, American journal of epidemiology.

[13]  D. Brat,et al.  Cancer susceptibility variants and the risk of adult glioma in a US case–control study , 2011, Journal of Neuro-Oncology.

[14]  Elisabeth Cardis,et al.  Brain tumour risk in relation to mobile telephone use: results of the INTERPHONE international case-control study. , 2010, International journal of epidemiology.

[15]  Melissa Bondy,et al.  Genome-wide association study identifies five susceptibility loci for glioma , 2009, Nature Genetics.

[16]  D. Bigner,et al.  Glioblastoma multiforme: a review of where we have been and where we are going , 2009, Expert opinion on investigational drugs.

[17]  Alexander R. Pico,et al.  Variants in the CDKN2B and RTEL1 regions are associated with high grade glioma susceptibility , 2009, Nature Genetics.

[18]  Ian F. Pollack,et al.  Pathologist Interobserver Variability of Histologic Features in Childhood Brain Tumors: Results from the CCG-945 Study , 2008, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[19]  S. Shete,et al.  GLIOGENE—an International Consortium to Understand Familial Glioma , 2007, Cancer Epidemiology Biomarkers & Prevention.

[20]  P. Kleihues,et al.  Epidemiology and etiology of gliomas , 2005, Acta Neuropathologica.

[21]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[22]  J. Eluf-Neto,et al.  Hospital visitors as controls in case-control studies. , 2001, Revista de saude publica.

[23]  Steff Lewis,et al.  Forest plots: trying to see the wood and the trees , 2001, BMJ : British Medical Journal.

[24]  G. Meijer.  GLOBOCAN 1: Cancer Incidence and Mortality Worldwide. , 2000 .

[25]  Jack L. Vevea,et al.  Fixed- and random-effects models in meta-analysis. , 1998 .

[26]  G. Fuller,et al.  Diagnostic discrepancies and their clinical impact in a neuropathology referral practice , 1997, Cancer.

[27]  D. Nelson,et al.  Central pathology review in clinical trials for patients with malignant glioma. A report of radiation therapy oncology group 83‐02 , 1995, Cancer.

[28]  J K McLaughlin,et al.  Selection of controls in case-control studies. II. Types of controls. , 1992, American journal of epidemiology.

[29]  S. Halabi,et al.  Hospital visitors as controls. , 1988, American journal of epidemiology.

[30]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[31]  R. Barnard,et al.  The classification of tumours of the central nervous system. , 1982, Neuropathology and applied neurobiology.

[32]  N. Breslow,et al.  Statistical methods in cancer research: volume 1- The analysis of case-control studies , 1980 .

[33]  M. Plummer,et al.  International agency for research on cancer. , 2020, Archives of pathology.

[34]  M. Graffar.  [Modern epidemiology]. , 1971, Bruxelles medical.